Skip to main content

HCA

HCA Healthcare, Inc.

Company with tickers: HCA

Market Cap
$86.89B
Shares Outstanding
221,839,800
CIK
860730
CUSIP
40412C101
13F Activity (30d)
46 filings 17 filers
Investor Relations
Investor relations

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$10,000,000,000
as of 2026-01-31
Remaining Authorization
$1,586,000,000
as of 2022-12-31 · not restated in filings since 2023-02-17
Program Utilization
84.1% $8,414,000,000 used of $10,000,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-03-31 YTD $1,571,000,000
2025-12-31 $10,067,000,000
2024-12-31 $6,042,000,000
2023-12-31 $3,811,000,000
2022-12-31 $7,000,000,000
2021-12-31 $8,215,000,000
2020-12-31 $441,000,000
2019-12-31 $1,031,000,000
2018-12-31 $1,530,000,000
2017-12-31 $2,051,000,000
2016-12-31 $2,751,000,000
2015-12-31 $2,397,000,000
2014-12-31 $1,750,000,000
2013-12-31 $500,000,000
2011-12-31 $1,503,000,000